Pulmonary capillary haemangiomatosis: a distinct entity?

Pulmonary capillary haemangiomatosis: a distinct entity?

Pulmonary capillary haemangiomatosis (PCH) is a rare and incompletely understood histopathological finding characterised by abnormal capillary proliferation within the alveolar interstitium, which has long been noted to share many overlapping features with pulmonary veno-occlusive disease (PVOD). Bu...

Full description

Bibliographic Details
Main Authors:	Jason Weatherald, Peter Dorfmüller, Frédéric Perros, Maria-Rosa Ghigna, Barbara Girerd, Marc Humbert, David Montani
Format:	Article
Language:	English
Published:	European Respiratory Society 2020-05-01
Series:	European Respiratory Review
Online Access:	http://err.ersjournals.com/content/29/156/190168.full

Similar Items

Heritable pulmonary hypertension: from bench to bedside
by: Barbara Girerd, et al.
Published: (2017-09-01)

Multiple gastrointestinal haemangiomatosis: A report of two cases
by: Shina Adefarakan, et al.
Published: (2024-01-01)

Pulmonary hypertension associated with neurofibromatosis type 1
by: Etienne-Marie Jutant, et al.
Published: (2018-08-01)

Screening for pulmonary arterial hypertension in systemic sclerosis
by: Jason Weatherald, et al.
Published: (2019-07-01)

Description, Staging and Quantification of Pulmonary Artery Angiophagy in a Large Animal Model of Chronic Thromboembolic Pulmonary Hypertension
by: Frédéric Perros, et al.
Published: (2020-11-01)

Multifocal infantile haemangiomatosis with hepatic involvement: two cases and treatment management
by: Antonio Ruggiero, et al.
Published: (2020-03-01)

Incidental finding of diffuse cavernous rectal haemangiomatosis during bowel cancer screening
by: Kushala W. M. Abeysekera, et al.
Published: (2019-11-01)

Increased oxidative stress and severe arterial remodeling induced by permanent high-flow challenge in experimental pulmonary hypertension
by: Fadel Elie, et al.
Published: (2011-09-01)

Clinical phenotypes and survival of pre-capillary pulmonary hypertension in systemic sclerosis.
by: David Launay, et al.
Published: (2018-01-01)

Implication of Potassium Channels in the Pathophysiology of Pulmonary Arterial Hypertension
by: Hélène Le Ribeuz, et al.
Published: (2020-09-01)

Nuclear factor κ-B is activated in the pulmonary vessels of patients with end-stage idiopathic pulmonary arterial hypertension.
by: Laura C Price, et al.
Published: (2013-01-01)

Pulmonary arterial hypertension registries: past, present and into the future
by: Jason Weatherald, et al.
Published: (2019-12-01)

Ventilatory efficiency in pulmonary vascular diseases
by: Jason Weatherald, et al.
Published: (2021-07-01)

Trichloroethylene increases pulmonary endothelial permeability: implication for pulmonary veno-occlusive disease
by: Julien Caliez, et al.
Published: (2020-10-01)

Precision medicine and personalising therapy in pulmonary hypertension: seeing the light from the dawn of a new era
by: Laurent Savale, et al.
Published: (2018-04-01)

Pulmonary hypertension associated with busulfan
by: Jean Hagenburg, et al.
Published: (2021-10-01)

Iron deficiency in pulmonary arterial hypertension: perspectives
by: Marceau Quatredeniers, et al.
Published: (2021-06-01)

The beneficial effect of suramin on monocrotaline-induced pulmonary hypertension in rats.
by: Mohamed Izikki, et al.
Published: (2013-01-01)

Association of pulmonary aspergilloma and allergic bronchopulmonary aspergillosis
by: D. Montani, et al.
Published: (2010-12-01)

The isobaric pulmonary arterial compliance in pulmonary hypertension
by: Denis Chemla, et al.
Published: (2021-05-01)

Acute decompensated pulmonary hypertension
by: Laurent Savale, et al.
Published: (2017-11-01)

Pulmonary Hypertension Induced by Right Pulmonary Artery Occlusion: Hemodynamic Consequences of Bmpr2 Mutation
by: Alban Todesco, et al.
Published: (2024-07-01)

Lipidomic Profile Analysis of Lung Tissues Revealed Lipointoxication in Pulmonary Veno-Occlusive Disease
by: Spiro Khoury, et al.
Published: (2022-12-01)

Pulmonary Vascular Disease and Cardiopulmonary Exercise Testing
by: Pierantonio Laveneziana, et al.
Published: (2020-08-01)

Absence of influence of gender and <it>BMPR2 </it>mutation type on clinical phenotypes of pulmonary arterial hypertension
by: Yaici Azzedine, et al.
Published: (2010-06-01)

Sex and gender in lung health and disease: more than just Xs and Ys
by: Jason Weatherald, et al.
Published: (2021-11-01)

Bridging the species divide: The limits of rat models in capturing human PVOD mechanisms
by: Frédéric Perros, et al.
Published: (2024-10-01)

Iron Deficiency in Pulmonary Arterial Hypertension: A Deep Dive into the Mechanisms
by: Marceau Quatredeniers, et al.
Published: (2021-02-01)

Non-Invasive Determination of Cardiac Output in Pre-Capillary Pulmonary Hypertension.
by: Frédéric Lador, et al.
Published: (2015-01-01)

Chronic thromboembolic pulmonary hypertension: a distinct disease entity
by: Irene Lang
Published: (2015-06-01)

Role of Store-Operated Ca<sup>2+</sup> Entry in the Pulmonary Vascular Remodeling Occurring in Pulmonary Arterial Hypertension
by: Bastien Masson, et al.
Published: (2021-11-01)

Factors predicting outcome after pulmonary endarterectomy.
by: Cécile Tromeur, et al.
Published: (2018-01-01)

Drug-induced pulmonary arterial hypertension: a recent outbreak
by: Gérald Simonneau, et al.
Published: (2013-09-01)

Updated Clinical Classification and Hemodynamic Definitions of Pulmonary Hypertension and Its Clinical Implications
by: Mithum Kularatne, et al.
Published: (2024-02-01)

Revisiting a Distinct Entity in Pulmonary Vascular Disease: Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
by: Munish Sharma, et al.
Published: (2021-04-01)

Pulmonary veno-occlusive disease: illustrative cases and literature review
by: Benoit Lechartier, et al.
Published: (2024-01-01)

Mortality trends in pulmonary arterial hypertension: Are we just spinning our wheels?
by: Jason G. E. Zelt, et al.
Published: (2022-10-01)

Monitoring of Hemodynamics With Right Heart Catheterization in Children With Pulmonary Arterial Hypertension
by: Julien Grynblat, et al.
Published: (2023-04-01)

The thromboxane receptor antagonist NTP42 promotes beneficial adaptation and preserves cardiac function in experimental models of right heart overload
by: Eamon P. Mulvaney, et al.
Published: (2022-12-01)

Extracellular matrix degradation pathways and fatty acid metabolism regulate distinct pulmonary vascular cell types in pulmonary arterial hypertension
by: Sharon Mumby, et al.
Published: (2021-03-01)